• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

LSP

DNA helix forming inside a test tube
Biotech

Gene therapy startup bursts forth from J&J and F-Prime incubator

AviadoBio exited stealth with $80 million from backers such as New Enterprise Associates and a C-suite led by Novartis veteran Lisa Deschamps. 
Nick Paul Taylor Dec 3, 2021 8:25am
Dermatologist

Evommune snags $83M for "Tylenol for itch," three other programs

Sep 9, 2021 7:30am
neon red heart outline on black background

Cardior gets $75M to run midphase antisense heart failure trial

Aug 25, 2021 8:25am
Euros

Bristol Myers powers LSP to record-breaking European VC fund

Mar 10, 2020 9:30am
Atlantic Innovo

Atlantic nets OTC clearance for wearable pelvic floor stimulator

Feb 7, 2020 11:25am
AM-Pharma CEO Erik van den Berg

Free of Pfizer, AM-Pharma raises €116M for phase 3

Jul 16, 2019 3:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings